A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients who received only an immune-based treatment to help their own immune ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

A new study sheds light on why promising cancer treatments can produce dramatically different results across patients.

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in Nature Communications, by a multidisciplinary team ...

If you have metastatic breast cancer that’s hormone receptor-positive (HR+) and HER2-negative, your treatment plan looks very different from how it might have decades ago. Instead of relying on ...

Jamie Dimon is trying to sketch a future in which artificial intelligence helps cure cancer and shortens the workweek, without turning mass layoffs into a social catastrophe. The longtime banking ...

Early-onset cancer creates overlapping workplace risks: anxiety and loneliness, social exclusion affecting up to half of patients, economic strain from high treatment spend, and exacerbation of talent ...